Related references
Note: Only part of the references are listed.Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Heinz Drexel et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Antiplatelet therapy after percutaneous coronary intervention
Dominick J. Angiolillo et al.
EUROINTERVENTION (2022)
Association of baseline platelet count with all-cause mortality after acute myocardial infarction
Pil Sang Song et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Meta-analysis of the relationship between interleu-kin-6 levels and the prognosis and severity of acute coronary syndrome
Chongzhe Yang et al.
CLINICS (2021)
Blood Platelet Count at Hospital Admission Impacts Long-Term Mortality in Patients with Acute Coronary Syndrome
Artur Malyszczak et al.
CARDIOLOGY (2020)
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes Results From a Randomized Trial
Maurizio Menichelli et al.
ANNALS OF INTERNAL MEDICINE (2020)
Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients The ISAR-REACT 5 Trial
Katharina Mayer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Use of PRECISE-DAPT Score and Admission Platelet Count to Predict Mortality Risk in Patients With Acute Coronary Syndrome
Nuccia Morici et al.
ANGIOLOGY (2019)
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
S. Schuepke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document
Hector M. Garcia-Garcia et al.
CIRCULATION (2018)
Themanagement of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
Cian P. McCarthy et al.
EUROPEAN HEART JOURNAL (2017)
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome
Angela Lowenstern et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial
Christina L. Fanola et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Impact of Thrombocytopenia on Outcome in Patients with Acute Coronary Syndromes: A Single Center Retrospective Study
Andreja Sinkovic et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy-Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial
Stefanie Schulz et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
CIRCULATION (2012)
Baseline Platelet Count and Clinical Outcome in Acute Coronary Syndrome
Yihua Wu et al.
CIRCULATION JOURNAL (2012)
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial
Diaa A. Hakim et al.
AMERICAN HEART JOURNAL (2011)
Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice
Tracy Y. Wang et al.
CIRCULATION (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of baseline platelet count. in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)
Eugenia Nikolsky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI trials)
Hung Q. Ly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction
C Mueller et al.
AMERICAN HEART JOURNAL (2006)
Share Paper
